All In MedTech

Device Trial Radar · NCT03934788

the Clinical Performance of the Oxysoft Daily Disposable Silicone Hydrogel Soft Contact Lens

A Prospective Randomized Controlled Study to Evaluate the Clinical Performance of OxySoft Silicone Hydrogel Soft Contact Lens

Last checked: Nov 20, 2026Latest source record: May 2, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

36

Actual

Start

Sep 26, 2018

Primary completion

Nov 29, 2018

Study completion Nov 29, 2018

Sponsor

Lead sponsor
Visco Vision Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Jens Medical Consulting Ltd.
First posted
May 2, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Supportive care
FDA-regulated device
No
Who can join
All sexes, from 20 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to demonstrate that the OxySoft silicone hydrogel soft contact lens could be prescribed as a supportive care for myopes.

Conditions

  • Myopia

Interventions

  • oxysoft (olifilcon C)Device

    subjects meet certain criteria will be administered randomly oxysoft on both eye for one month on daily wear single use modality.

  • Si-Hy (olifilcon B)Device

    subjects meet certain criteria will be administered randomly Si-Hy on both eye for one month on daily wear single use modality.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Log MAR visual acuitiesTime frame: 1 month

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Taipei TzuChi Hopsital, Buddhist Tzu Chi Medical Foundation

    New Taipei City, Taiwan

  • Tri-Service General Hospital_Tingjhou

    Taipei, Taiwan

  • MayKay Memorial Hospital

    Taipei, Taiwan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.